These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 10690168

  • 21. Evaluation of quantitative measurements of hepatitis C virus RNA to predict sustained response to interferon by genotype.
    Chayama K, Suzuki F, Tsubota A, Akuta N, Someya T, Kobayashi M, Arase Y, Saitoh S, Suzuki Y, Ikeda K, Kumada H.
    J Virol Methods; 2001 Jun; 95(1-2):33-45. PubMed ID: 11377711
    [Abstract] [Full Text] [Related]

  • 22. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy.
    Suzuki T, Tanaka E, Matsumoto A, Urushihara A, Sodeyama T.
    J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506
    [Abstract] [Full Text] [Related]

  • 23. Benefit of hepatitis C virus core antigen assay in prediction of therapeutic response to interferon and ribavirin combination therapy.
    Takahashi M, Saito H, Higashimoto M, Atsukawa K, Ishii H.
    J Clin Microbiol; 2005 Jan; 43(1):186-91. PubMed ID: 15634970
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Hepatitis C virus (HCV) RNA level determined by second-generation branched-DNA probe assay as predictor of response to interferon treatment in patients with chronic HCV viremia.
    Furusyo N, Hayashi J, Kashiwagi K, Nakashima H, Nabeshima S, Sawayama Y, Kinukawa N, Kashiwagi S.
    Dig Dis Sci; 2002 Mar; 47(3):535-42. PubMed ID: 11911338
    [Abstract] [Full Text] [Related]

  • 26. Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: implications for clinical management of patients with chronic hepatitis C virus infection.
    Halfon P, Pénaranda G, Bourlière M, Khiri H, Masseyeff MF, Ouzan D.
    J Med Virol; 2006 Feb; 78(2):208-15. PubMed ID: 16372298
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma.
    Murphy DG, Côté L, Fauvel M, René P, Vincelette J.
    J Clin Microbiol; 2000 Nov; 38(11):4034-41. PubMed ID: 11060065
    [Abstract] [Full Text] [Related]

  • 31. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method.
    Hawkins A, Davidson F, Simmonds P.
    J Clin Microbiol; 1997 Jan; 35(1):187-92. PubMed ID: 8968905
    [Abstract] [Full Text] [Related]

  • 32. Performance of the New Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, assay.
    Beld M, Sentjens R, Rebers S, Weegink C, Weel J, Sol C, Boom R.
    J Clin Microbiol; 2002 Mar; 40(3):788-93. PubMed ID: 11880394
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays.
    Konnick EQ, Williams SM, Ashwood ER, Hillyard DR.
    J Clin Microbiol; 2005 May; 43(5):2133-40. PubMed ID: 15872232
    [Abstract] [Full Text] [Related]

  • 34. Preclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNA.
    Nolte FS, Thurmond C, Fried MW.
    J Clin Microbiol; 1995 Jul; 33(7):1775-8. PubMed ID: 7665645
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV Monitor, Version 2.0, assays in HCV genotype 4 infection.
    Jessner W, Watkins-Riedel T, Müller C, Formann E, Gschwantler M, Ferenci P.
    J Viral Hepat; 2007 Nov; 14(11):775-81. PubMed ID: 17927613
    [Abstract] [Full Text] [Related]

  • 36. Viral kinetics can predict early response to alpha-interferon in chronic hepatitis C.
    Walsh KM, Good T, Cameron S, Thorburn D, McCruden EA, Mills PR, Morris AJ.
    Liver; 1998 Jun; 18(3):191-5. PubMed ID: 9716230
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients.
    Toyoda H, Nakano S, Kumada T, Takeda I, Sugiyama K, Osada T, Kiriyama S, Orito E, Mizokami M.
    J Med Virol; 1996 Apr; 48(4):354-9. PubMed ID: 8699168
    [Abstract] [Full Text] [Related]

  • 39. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications.
    Gretch DR, dela Rosa C, Carithers RL, Willson RA, Williams B, Corey L.
    Ann Intern Med; 1995 Sep 01; 123(5):321-9. PubMed ID: 7542853
    [Abstract] [Full Text] [Related]

  • 40. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
    Gallegos-Orozco JF, Fuentes AP, Olivera-Martinez MA, Gutiérrez-Reyes G, Cortina D, Oregel JA, Pérez-Pruna C, Sixtos MS, Cruz-Castellanos S, Soto-Ramírez LE, Rodríguez-Díaz R, Fuentes-Romero L, Gutiérrez-Ruiz MC, Kershenobich D.
    Rev Invest Clin; 2003 Sep 01; 55(2):138-42. PubMed ID: 12827916
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.